Jiangsu Gdk Biological Technology Co., Ltd (SHA:688670)
China · Delayed Price · Currency is CNY 17.62
+0.08 (0.46%)
Mar 31, 2026, 10:04 AM CST
SHA:688670 Market Cap
SHA:688670 has a market cap or net worth of 2.17 billion as of March 30, 2026. Its market cap has increased by 47.36% in one year.
Market Cap
2.17B
Enterprise Value
2.07B
Revenue
113.23M
Ranking
n/a
PE Ratio
n/a
Stock Price
17.62
Market Cap Chart
Since August 2, 2021, SHA:688670's market cap has decreased from 7.30B to 2.17B, a decrease of -70.26%. That is a compound annual growth rate of -22.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 2.17B | -12.95% |
| Dec 31, 2025 | 2.49B | 66.91% |
| Dec 31, 2024 | 1.49B | -57.41% |
| Dec 29, 2023 | 3.51B | -7.32% |
| Dec 30, 2022 | 3.78B | -43.20% |
| Dec 31, 2021 | 6.66B | -8.72% |
| Aug 2, 2021 | 7.30B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novoprotein Scientific | 2.79B |
| Shanghai Serum Bio-Technology | 2.75B |
| Jilin Jian Yisheng Pharmaceutical | 2.67B |
| Shandong Sito Bio-technology | 2.60B |
| Shanghai Universal Biotech | 2.60B |
| Hubei Goto Biopharm | 2.38B |
| Zhejiang East Asia Pharmaceutical | 2.38B |
| Guiyang Xintian Pharmaceutical | 2.36B |